Taxus chinensis
Taxus chinensis
Taxus chinensis is a traditional Chinese plant. While its specific uses in traditional medicine are not well-documented, it has shown promise in modern research for its potential antitumor properties. Studies indicate that compounds 4 and 5 from Taxus chinensis var. mairei have demonstrated significant triglyceride-lowering activity in adipocytes, though the evidence is still preliminary. Additionally, an exosomal-cisplatin nanoplatform developed using extracts from this plant has shown enhanced tumor targeting and reduced systemic toxicity compared to conventional methods. Taxus tablets have also been found to exhibit comparable antitumor efficacy to paclitaxel injection with good tolerance, supporting their development as a potential oral antitumor agent. The Hongwu mixture (HWM) containing extracts of Taxus chinensis has shown reduced viability and proliferation in TNBC cells, potentially through ZNF143-mediated SAV1 activation. No major safety issues or drug interactions have been recorded for this plant, though further research is needed to fully understand its therapeutic potential and mechanisms of action.
- Best evidence
- D
- Cautions
- —
Informational only. Traditional use does not mean proven effectiveness. Evidence and safety vary — check the cited sources.
What the science says
- This study presented an exosomal-cisplatin nanoplatform derived from Taxus chinensis for TNBC treatment, showing enhanced therapeutic efficacy with reduced systemic toxicity.
- Taxus tablets showed comparable antitumor efficacy to PTX injection with good tolerance, supporting their development as an oral antitumor agent.
- Hongwu mixture (HWM) inhibited triple-negative breast cancer cell proliferation and promoted apoptosis by regulating ZNF143/SAV1 signaling.
- Compounds 4 and 5 from Taxus chinensis var. mairei showed significant triglyceride-lowering activity in adipocytes, with IC50 values comparable to fenofibrate.
Frequently asked questions
What is Taxus chinensis?
Taxus chinensis (Taxus chinensis) is a plant documented in FolkKB's traditional-medicine reference, drawn from sourced literature and cross-checked against the evidence.
What does the scientific evidence say about Taxus chinensis?
4 sourced findings are recorded for Taxus chinensis; the strongest carries evidence grade D. For example: This study presented an exosomal-cisplatin nanoplatform derived from Taxus chinensis for TNBC treatment, showing enhanced therapeutic efficacy with reduced systemic toxicity.
How strong is the evidence for Taxus chinensis?
The strongest finding for Taxus chinensis carries evidence grade D — preliminary or traditional. Grades run A (strongest) to D (preliminary or traditional).
Is Taxus chinensis safe? What are the side effects?
No major safety issues are recorded for Taxus chinensis in our sources, but the data may be incomplete. Consult a qualified professional before use.
Does Taxus chinensis interact with medications?
No drug interactions are recorded for Taxus chinensis in our sources. This does not rule them out — check with a pharmacist.
Is Taxus chinensis a proven treatment?
No. FolkKB is informational only. Traditional use and early findings are not proof of efficacy or safety — consult a qualified professional and never self-treat.
Sources
- T2 Hongwu mixture exerts inhibition on triple-negative breast cancer by regulating SAV1/Hippo signaling through ZNF143. literature abstract metadata
- T2 A semimechanistic PK/PD model-informed Taxus tablets' development: Accelerating early clinical translation of a taxane-based antitumor agent. literature abstract metadata
- T2 Intelligent plant exosomes synergize miRNAs and cisplatin for spatiotemporally precise multimodal treatment for TNBC with high safety. literature abstract metadata
- T2 2(3→20)-abeo-taxoids with adipogenesis inhibitory activity from the leaves and twigs of Taxus chinensis var. mairei. literature abstract metadata